Outpatient Therapies Physicians Special Programs Patient Conditions Rehabilitation Orthopaedics

 
 

Kernan Hospital

Home > Medical Reference > Complementary Medicine

Aminocamptothecin


Pronunciation

(a min o camp to THE sin)


Synonyms

9-AC; 9-Aminocamptothecin; NSC-603071


Generic Available

No


Use - Unlabeled/Investigational

Phase II trials: Relapsed lymphoma, refractory breast cancer, nonsmall cell lung cancer, untreated colorectal carcinoma


Contraindications

Hypersensitivity to aminocamptothecin or any component of the formulation


Adverse Reactions

Frequency not defined.

Central nervous system: Fatigue

Dermatologic: Alopecia

Gastrointestinal: Nausea, vomiting, diarrhea, mucositis, anorexia

Hematologic: Neutropenia (may be dose-limiting), thrombocytopenia (reversible, but may be dose-limiting depending on administration schedule), anemia


Drug Interactions

Patients taking anticonvulsants that induce hepatic enzymes have less toxicity and can tolerate higher doses of aminocamptothecin.


Stability

Store ampuls at room temperature. Contents of ampul are added to vial (supplied) containing 24.5 mL of special diluent. Resulting aminocamptothecin concentration is 100 mcg/mL. Further dilution with special diluent for administration via syringe pump is acceptable. May further dilute with NS if resulting concentration is <1 mcg/mL. Diluted solutions are stable for 28 hours at room temperature. Undiluted aminocamptothecin should not contact plastic items.


Mechanism of Action

Aminocamptothecin binds to topoisomerase I, stabilizing the cleavable DNA-topoisomerase I complex, resulting in arrest of the replication fork and inhibition of DNA synthesis.


Pharmacodynamics/Kinetics

Ratio of lactone to total drug is 8.7 ± 4.7% because of instability of aminocamptothecin lactone in plasma.

Distribution: Vd: 46-92 L

Metabolism: None identified

Half-life elimination: Terminal: 8-17 hours for total aminocamptothecin

Excretion: Urine (32% of total drug delivered)


Dosage

I.V.: Adults: 45-59 mcg/m 2 /hour for 72 hours as a continuous infusion; repeat every 2 weeks or 35 mcg/m 2 /hour as a 72-hour continuous infusion


Administration

Administer by continuous I.V. infusion.


Monitoring Parameters

WBC with differential, platelet count


Dental Health: Effects on Dental Treatment

No significant effects or complications reported


Dental Health: Vasoconstrictor/Local Anesthetic Precautions

No information available to require special precautions


Mental Health: Effects on Mental Status

May cause sedation


Mental Health: Effects on Psychiatric Treatment

May cause GI side effects; concomitant use with SSRIs, lithium, or vaproic acid may produce additive effects; monitor. May cause neutropenia and thrombocytopenia; monitor if using concomitantly with clozapine, valproic acid, and carbamazepine.


Oncology: Emetic Potential

Moderate (30% to 60%)


Oncology: Vesicant

No


Dosage Forms

Injection: 5 mg ampul


References

Grossman SA, Hochberg F, Fisher J, et al, "Increased 9-Aminocamptothecin Dose Requirements in Patients on Oral Anticonvulsants. NAPTT CNS Consortium. The New Approaches to Brain Tumor Therapy," Cancer Chemother Pharmacol , 1998, 42(2):118-26.

Iyer L and Ratain MJ, "Clinical Pharmacology of Camptothecins," Cancer Chemother Pharmacol , 1998, 42(Suppl):31-43.

Potmesil M, Arbuck SG, Takimoto CH, et al, "9-Aminocamptothecin and Beyond. Preclinical and Clinical Studies," Ann N Y Acad Sci , 1996, 803:231-46.

Takimota CH, Wright J, and Arbuck SG, "Clinical Applications of the Camptothecins," Biochim Biophys Acta , 1998, 1400(1-3):107-19.


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Physicians Special Programs Patient Conditions Physical Therapy